Use of intravenous brivaracetam in status epilepticus: A multicenter registry
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Use of intravenous brivaracetam in status epilepticus: A multicenter registry
Authors
Keywords
-
Journal
EPILEPSIA
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-07-01
DOI
10.1111/epi.16094
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus
- (2018) Adam Strzelczyk et al. EPILEPSIA
- Intravenous brivaracetam in status epilepticus: Correlation between loading dose, plasma levels and clinical response
- (2018) Irene Aicua-Rapun et al. EPILEPSY RESEARCH
- Acute and long-term effects of brivaracetam and brivaracetam-diazepam combinations in an experimental model of status epilepticus
- (2017) Jerome Niquet et al. EPILEPSIA
- Treatment of refractory and super-refractory status epilepticus with brivaracetam: A cohort study from two German university hospitals
- (2017) Adam Strzelczyk et al. EPILEPSY & BEHAVIOR
- Refractory and super-refractory status epilepticus in adults: a 9-year cohort study
- (2016) L. Delaj et al. ACTA NEUROLOGICA SCANDINAVICA
- Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein
- (2016) Martyn D. Wood et al. EPILEPSIA
- Brivaracetam add-on for refractory focal epilepsy
- (2016) Simona Lattanzi et al. NEUROLOGY
- A definition and classification of status epilepticus - Report of the ILAE Task Force on Classification of Status Epilepticus
- (2015) Eugen Trinka et al. EPILEPSIA
- Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action
- (2015) Jean-Marie Nicolas et al. EPILEPSIA
- Comparison of the effectiveness of four antiepileptic drugs in the treatment of status epilepticus according to four different efficacy criteria
- (2015) Juliane Redecker et al. EPILEPSY & BEHAVIOR
- An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam
- (2015) Stephen L. Yates et al. EPILEPSY & BEHAVIOR
- Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: Relationship to anti-convulsant properties
- (2011) Michel Gillard et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A
- (2008) A Matagne et al. BRITISH JOURNAL OF PHARMACOLOGY
- Status Epilepticus Severity Score (STESS)
- (2008) Andrea O. Rossetti et al. JOURNAL OF NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started